China National Chemical Engineering (601117) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
25 Mar, 2026Executive summary
Achieved revenue of ¥189.5 billion, up 1.97% year-over-year; net profit attributable to shareholders reached ¥6.44 billion, up 13.15%.
Total assets grew to ¥247.35 billion, a 5.97% increase from the previous year.
New contract value reached ¥403.7 billion, up 10.01% year-over-year, with overseas contracts accounting for 30.85%.
Proposed total cash dividend of ¥2.11 per 10 shares, with a payout ratio of 20.02%.
Financial highlights
Operating income: ¥189.5 billion, up 1.97% year-over-year.
Net profit attributable to shareholders: ¥6.44 billion, up 13.15% year-over-year.
Operating cash flow: ¥1.44 billion, down 83.45% year-over-year due to reduced net inflow from financial company activities.
Basic and diluted EPS: ¥1.06, up 13.98% year-over-year.
Gross margin: 10.99%, up 0.56 percentage points year-over-year.
Outlook and guidance
2026 targets: new contracts of ¥410 billion, revenue of ¥195 billion, and total profit of ¥8.5 billion.
Focus on high-end chemical engineering, new materials, and digital transformation.
Continued expansion in international markets and new energy sectors.
Latest events from China National Chemical Engineering
- Revenue and net profit rose over 4% year-over-year, driven by strong new contracts and overseas growth.601117
H2 202418 Dec 2025 - Net profit rose 9.26% year-over-year to ¥3.10 billion on stable revenue and higher margins.601117
H1 20255 Dec 2025 - Net profit grew 10.28% year-over-year to RMB 4.23 billion on rising revenue and new contracts.601117
Q3 202530 Oct 2025 - Q3 net profit surged 28.57% year-over-year, but operating cash flow turned negative.601117
Q3 202413 Jun 2025 - Revenue and profit declined, but gross margin and new contracts improved in H1 2024.601117
H1 202413 Jun 2025 - Net profit surged 18.77% in Q1 2025 despite a slight revenue dip and negative cash flow.601117
Q1 20256 Jun 2025